---
document_datetime: 2025-11-10 12:34:59
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nemluvio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: nemluvio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.1222352
conversion_datetime: 2025-12-14 21:36:24.319903
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Nemluvio

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber    | Scope                               | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|-------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | B.II.b.2.cReplacementor additionofa | 10/11/2025                          |                                          | Annex II and                    |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | manufacturerresponsibleforimportation and/or batch release - B.1I1.b.2.c.1 Not including batch control/testing - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     | PL   | EMA/VR/0000310765   |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|---------------------|
| Variation type IA / EMA/VR/0000306885 | Thiswas anapplicationfor agroupof variations. B.II.b.1 Replacement or addition of a manufacturingsiteforpartor all of the manufacturingprocessofthefinished product - B.1I1.b.1.a Secondary packaging site - Accepted B.II.b.1Replacement or addition of a manufacturingsiteforpart or all of the manufacturing process of the finished product - B.I1.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturingprocessof thefinished product - B.I1.b.1.a Secondary packaging site -Accepted | 20/10/2025 | N/A |      |                     |
| Variation type IB / EMA/VR/0000296279 | Thiswas anapplicationfor agroupof variations. B.II.b.5 Change to in-process tests or limits appliedduring themanufactureof the finished product - B.II.b.5.c Deletion of a non-significant in-process test - Accepted                                                                                                                                                                                                                                                                                                                                                       | 16/10/2025 | N/A |      |                     |

<div style=\"page-break-after: always\"></div>

|                                       | B.I1.b.3 Change in the manufacturing process of the finished product, including an intermediateusedinthemanufactureof the finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted                                                                             |            |     |                        |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|
| Variation typeIB/ EMA/VR/0000281966   | B.II.f.1.bExtensionoftheshelflifeofthe finishedproduct-B.II.f.1.b.5Extension of the shelf-life of a biological/ immunological medicinal product in accordancewith an approved stability protocol-Accepted                                                                                | 29/07/2025 |     | SmPC                   |
| Variation type IA / EMA/VR/0000288003 | A.5Change in thename and/or addressofa manufacturer/importer of the finished product (including batch release or quality control testing sites)-A.5.bThe activities for which the manufacturer/importer is responsible do not include batch release - Accepted                           | 25/07/2025 | N/A |                        |
| Variation typeIB/ EMA/VR/0000278836   | C.1.7 Deletion of:-C.1.7.a a pharmaceutical form - Accepted C.I.7.a-To delete thepharmaceutical form powder and solvent for solution for injection inpre-filled syringefrom theNemluvio marketing authorisation (EU/1/24/1901/004).TheAnnexes are updatedaccordingly.Additionally,theMAH | 17/07/2025 |     | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|                                         | tooktheopportunitytoamendsection4.8of the SmPC with information on worsening of asthma and superficial fungal infections, as requested by the Rapporteur, and made editorial changes to the PI in DK, DE, FI, IT, NO,PL,andSEtoimplement changesthat were not implemented during previous linguistic review and to correct for typographical errors. Furthermore, the MAH tooktheopportunitytoupdatethelistof localrepresentatives forBG,CZ,EE,GR,FR, HR, CY, LV,LT, HU, MT, RO, SI and SK in section 6 of the PL.   |            |     |
|-----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeIA_IN / EMA/VR/0000253858 | B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.1I.b.1.a Secondary packaging site - Accepted                                                                                                                                                                                                                                                                                                                                       | 05/03/2025 | N/A |